THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 106 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 2.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $4,000 | +33.3% | 138 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | +50.0% | 138 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -33.3% | 138 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 138 | +17.9% | 0.00% | – |
Q4 2018 | $3,000 | +200.0% | 117 | +588.2% | 0.00% | – |
Q3 2018 | $1,000 | – | 17 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 17 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 17 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 17 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 17 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 17 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 17 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 17 | 0.0% | 0.00% | – |
Q3 2015 | $0 | – | 17 | -34.6% | 0.00% | – |
Q2 2015 | $0 | – | 26 | 0.0% | 0.00% | – |
Q1 2015 | $0 | – | 26 | +52.9% | 0.00% | – |
Q4 2014 | $0 | – | 17 | 0.0% | 0.00% | – |
Q3 2014 | $0 | – | 17 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |